» Articles » PMID: 6970154

In Vitro and in Vivo Analysis of the PABA Test Compared with the Lundh Test--influence of Intraluminal PH

Overview
Journal Gut
Specialty Gastroenterology
Date 1981 Jan 1
PMID 6970154
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Lundh test and PABA test results were compared in 50 patients. In the resulting correlation curve three areas of interest were differentiated: (1) an area with mean tryptic activity, found in the Lundh test, below 4 U/ml, where an abnormal PABA test result was also seen; (2) an intermediate area from 4 to 9 U/ml, where PABA test results may be found in discordance with the Lundh test; (3) the normal level, where PABA excretion was shown to be independent of intestinal chymotrypsin activity. In experiments in vitro on the kinetics of the hydrolysis of BTPABA by chymotrypsin the profound influence of the pH on Km and Vmax was shown. This influence of the pH explains why in the intermediate area of pancreatic dysfunction normal PABA test results were found in a number of cases. A higher mean pH level of the Lundh test aspirates was found for patients with a normal PABA test result than for patients with an abnormal PABA test.

Citing Articles

Optimum dose of bentiromide.

Imondi A Dig Dis Sci. 1983; 28(9):859-60.

PMID: 6603959 DOI: 10.1007/BF01296911.


BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.

Delchier J, Soule J Gut. 1983; 24(4):318-25.

PMID: 6601041 PMC: 1419965. DOI: 10.1136/gut.24.4.318.


Comparative study of pancreatic polypeptide (PP) secretion, endocrine and exocrine function, and structural damage in chronic alcohol induced pancreatitis (CAIP).

Mee A, Klaff L, Girdwood A, Paul M, Tyler M, Marks I Gut. 1983; 24(7):642-7.

PMID: 6345282 PMC: 1420034. DOI: 10.1136/gut.24.7.642.


Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Hubbard V, WOLF R, Lester L, Egge A Dig Dis Sci. 1984; 29(10):881-9.

PMID: 6206989 DOI: 10.1007/BF01312475.


Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.

Mee A, Girdwood A, Walker E, Gilinsky N, KOTTLER R, Marks I Gut. 1985; 26(11):1257-62.

PMID: 3877666 PMC: 1432929. DOI: 10.1136/gut.26.11.1257.


References
1.
Gyr K, Stalder G, Schiffmann I, Fehr C, Vonderschmitt D, FAHRLAENDER H . Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT). Gut. 1976; 17(1):27-32. PMC: 1411054. DOI: 10.1136/gut.17.1.27. View

2.
Nousia-Arvanitakis S, Arvanitakis C, Desai N, Greenberger N . Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid. J Pediatr. 1978; 92(5):734-7. DOI: 10.1016/s0022-3476(78)80139-5. View

3.
Sacher M, Kobsa A, SHMERLING D . PABA screening test for exocrine pancreatic function in infants and children. Arch Dis Child. 1978; 53(8):639-41. PMC: 1545053. DOI: 10.1136/adc.53.8.639. View

4.
Bornschein W, Goldmann F, Dressler J . [Diagnosis of exocrine pancreatic malfunction with a synthetic peptide specific for chymotrypsine (author's transl)]. Klin Wochenschr. 1978; 56(4):197-205. DOI: 10.1007/BF01705383. View

5.
COOK H, Lennard-Jones J, Sherif S, Wiggins H . Measurement of tryptic activity in intestinal juice as a diagnostic test of pancreatic disease. Gut. 1967; 8(4):408-14. PMC: 1552540. DOI: 10.1136/gut.8.4.408. View